ArticleJournal of Cancer2021

HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer.

Clara Yuri Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.